These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22067520)

  • 1. Levosimendan in two neonates with ischemic heart failure and pulmonary hypertension.
    De Carolis MP; Piastra M; Bersani I; Pardeo M; Stival E; Tempera A; Romagnoli C; Conti G; De Rosa G
    Neonatology; 2012; 101(3):201-5. PubMed ID: 22067520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan and pulmonary hypertension.
    Cavusoglu Y; Beyaztas A; Birdane A; Ata N
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
    [No Abstract]   [Full Text] [Related]  

  • 3. Inotropic support in the NICU: ever more compounds in search of guidance? Commentary on J. Esch et al.: differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation (Neonatology 2012;101:192–200) and M.P. De Carolis et al.: levosimendan in two neonates with ischemic heart failure and pulmonary hypertension (Neonatology 2012;101:201–205).
    Thewissen L; Allegaert K
    Neonatology; 2012; 101(3):206-9. PubMed ID: 22067565
    [No Abstract]   [Full Text] [Related]  

  • 4. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS; Sandell EP
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L; Põder P
    Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
    Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
    Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Kerbaul F; Rondelet B; Demester JP; Fesler P; Huez S; Naeije R; Brimioulle S
    Crit Care Med; 2006 Nov; 34(11):2814-9. PubMed ID: 16971854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising new inotrope: levosimendan.
    Fotbolcu H; Duman D
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
    García González MJ; Domínguez Rodríguez A
    Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL; Fitzpatrick JT
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan in heart failure after surgical repair of cardiac rupture.
    Torrado H; Ventura JL; Ruiz-Majoral A; Farrero E; Rodriguez-Castro D; Carrio ML; Miralles A
    Minerva Cardioangiol; 2009 Feb; 57(1):137-8. PubMed ID: 19202525
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of acute cardiac failure by intracoronary administration of levosimendan.
    Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan: a new approach for the treatment of patients with severe heart failure. A brief summary based on a clinical case.
    Morais J; Dias B; Pontes N
    Rev Port Cardiol; 2003; 22(7-8):941-8. PubMed ID: 14587161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute hemodynamic and clinical effects of a new inotropic agent, levosimendan, in patients with severe heart failure].
    Porcu M; Orrù P
    Ital Heart J Suppl; 2001 Feb; 2(2):205-6. PubMed ID: 11255888
    [No Abstract]   [Full Text] [Related]  

  • 18. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levosimendan in heart failure].
    Scelsi L; Campana C; Ghio S; Monti L; Opasich C; De Feo S; Cobelli F; Orlandi M; Di Pasquale G; Tavazzi L
    Recenti Prog Med; 2004; 95(7-8):376-83. PubMed ID: 15303549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
    Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
    Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.